title: Cancer vaccines: limited success but the research should remain viable.
authors.affiliation: a Cancer Immunology and Immunotherapy Center , St Savas Cancer Hospital , Athens , Greece.
authors.forename: Constantin N
authors.initials: CN
authors.lastname: Baxevanis
authors.affiliation: a Cancer Immunology and Immunotherapy Center , St Savas Cancer Hospital , Athens , Greece.
authors.forename: Sonia A
authors.initials: SA
authors.lastname: Perez
mesh_terms: D000818:Animals; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research / Q000379:methods*; D019496:Cancer Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D059016:Tumor Microenvironment
chemical_list: D000074322:Antineoplastic Agents, Immunological; D019496:Cancer Vaccines